- Case-Based Modules
- Initial Evaluation
- Dermatologic Manifestations
- Oral Manifestations
- OIs: Prophylaxis
- OIs: Treatment
- Antiretroviral Rx
- Antiretroviral Rx: Resistance
- Antiretroviral Rx: Adverse Effects
- Drug-Drug Interactions
- Postexposure Prophylaxis
- Perinatal Transmission
- Special Populations
- Prevention for Positives
- Challenging Unknowns
- Resource-Limited Settings
- Interactive Tutorials
- Routine HIV Screening
- Oraquick Advance Rapid HIV Test
- HIV Integration
- This program is funded through Health Resources and Services Administration, US Department of Health and Human Services.
Resource-Limited Settings
Question | Discussion | References
Newly Diagnosed HIV and Active Tuberculosis: Antiretroviral Therapy and Co-trimoxazole Prophylaxis
You answered:
 |
Start antiretroviral therapy as soon as possible (within 2 to 8 weeks) following initiation of directly observed therapy for TB. |
|---|
This answer is correct. Current World Health Organization (WHO) Guidelines, supported by evidence from randomized controlled trials, support initiation of antiretroviral therapy as soon as possible following initiation of anti-TB therapy for HIV-infected patients with active TB.
[Back to Case Question | Proceed to Case Discussion]
Copyright © 2004-2011 University of Washington